Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 14, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.4K

Leukodystrophies.

Amy T Waldman

    Continuum (Minneapolis, Minn.)
    |February 13, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Early recognition of leukodystrophies, a group of neurodegenerative disorders, is crucial for timely intervention. This review aids clinicians in diagnosing and managing these complex conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Normative modeling for quantitative brain MRI phenotyping and biomarker discovery for pediatric leukodystrophies.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026
    Same author

    Performance outcomes of the PEDI-CAT for assessing functional ability in the population with leukodystrophy.

    Developmental medicine and child neurology·2026
    Same author

    Role of Tocilizumab in Severe CNS Inflammatory Presentations in Children.

    Neurology·2026
    Same author

    Severe retinal vasculopathy associated with myelin oligodendrocyte glycoprotein antibody optic neuritis in a toddler.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2026
    Same author

    Design of a Pediatric Low Motor Function Item Battery in leukodystrophies.

    Molecular genetics and metabolism·2026
    Same journal

    Key Considerations in Telestroke Program Management.

    Continuum (Minneapolis, Minn.)·2026
    Same journal

    Neurology's Action Potential: Delivering on the Promise of Brain Health.

    Continuum (Minneapolis, Minn.)·2026
    Same journal

    Erratum.

    Continuum (Minneapolis, Minn.)·2026
    Same journal

    Management of Large Artery Atherosclerosis.

    Continuum (Minneapolis, Minn.)·2026
    Same journal

    Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

    Continuum (Minneapolis, Minn.)·2026
    Same journal

    Stroke in Children and Younger Adults.

    Continuum (Minneapolis, Minn.)·2026
    See all related articles

    Area of Science:

    • Neurology
    • Genetics
    • Pediatrics

    Background:

    • Leukodystrophies are neurodegenerative disorders often diagnosed late, after irreversible nervous system damage.
    • Advances in neuroimaging and genetics are expanding the field of leukodystrophy research.
    • Early identification is critical for initiating potential therapeutic interventions.

    Observation:

    • Leukodystrophy symptoms can mimic common pediatric disorders, delaying diagnosis.
    • Accurate interpretation of MRI and genetic results requires understanding clinical and biochemical features.
    • Delayed diagnosis can lead to irreversible central and peripheral nervous system injury.

    Findings:

    • This article summarizes key symptoms, diagnostic evaluations, and current therapies for leukodystrophies.

    Related Experiment Videos

    Last Updated: Feb 14, 2026

    An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
    07:45

    An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

    Published on: October 21, 2014

    8.4K
  • It highlights recent advances in the management of these rare diseases.
  • The review aims to improve clinical recognition and diagnostic accuracy.

    • Implications:

    • Improved understanding can lead to earlier diagnosis and intervention for leukodystrophies.
    • Enhanced diagnostic strategies may mitigate irreversible neurological damage.
    • This knowledge empowers clinicians to provide more effective patient management.